Defining the role of IL-33/ST2 axis in vascular injury in hypertension

Guzik, Tomasz (Principal Investigator)

Deanery of Clinical Sciences

Status	Active
Effective start/end date	1/08/23 → 31/07/26

Funding

British Heart Foundation: £275,288.00

1 Article

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
Lawson, H., Holt-Martyn, J. P., Dembitz, V., Kabayama, Y., Wang, L. M., Bellani, A., Atwal, S., Saffoon, N., Durko, J., van de Lagemaat, L. N., De Pace, A. L., Tumber, A., Corner, T., Salah, E., Arndt, C., Brewitz, L., Bowen, M., Dubusse, L., George, D. & Allen, L. & 8 others, Guitart, A. V., Fung, T. K., So, C. W. E., Schwaller, J., Gallipoli, P., O'Carroll, D., Schofield, C. J. & Kranc, K. R., Jun 2024, In: nature cancer. 5, 6, p. 916-937 22 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File